Cannara Biotech Inc. (TSX:LOVE)
1.870
+0.030 (1.63%)
At close: Mar 4, 2026
39.55% (1Y)
| Market Cap | 184.72M +69.8% |
| Revenue (ttm) | 112.25M +28.5% |
| Net Income | 11.81M +77.9% |
| EPS | 0.12 +61.6% |
| Shares Out | 98.78M |
| PE Ratio | 15.69 |
| Forward PE | 13.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 21,270 |
| Average Volume | 50,582 |
| Open | 1.840 |
| Previous Close | 1.840 |
| Day's Range | 1.820 - 1.880 |
| 52-Week Range | 1.060 - 2.070 |
| Beta | 0.34 |
| RSI | 54.14 |
| Earnings Date | Apr 24, 2026 |